On the recordJuly 26, 2017
These regulatory requirements are an important safeguard to ensure that drugs with potentially dangerous characteristics and side effects are safely and carefully distributed.
Source
congress.govEditor's note · Context
Conyers discusses the balance between drug safety regulations and competition in the market.
Share & report
More from John Conyers
Oct 3, 2017
How much time remains on both sides? The SPEAKER pro tempore. The gentleman from Michigan has 2\1/2\ minutes remaining, and the gentlewoman from Georgia has 2\1/2\ minutes remaining.
Oct 3, 2017
I demand a recorded vote. A recorded vote was ordered. The SPEAKER pro tempore. This will be a 5-minute vote. The vote was taken by electronic device, and there were--ayes 237, noes 189, not voting 7, as follows: [Roll No. 549] AYES--237…
Jun 29, 2017
To close. Mr. Speaker, H.R. 3003 is not making our communities safer. If it was, the bill's sponsors would have heeded the strong opposition of organizations like the National Fraternal Order of Police, who stated that, ``withholding…
Other voices in this conversation
